80 FR 59791 - National Cancer Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 80, Issue 191 (October 2, 2015)

Page Range		59791-59791
FR Document		2015-25068

Federal Register, Volume 80 Issue 191 (Friday, October 2, 2015)

[Federal Register Volume 80, Number 191 (Friday, October 2, 2015)]
[Notices]
[Page 59791]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-25068]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel Bridging the Gap Between Cancer Mechanism and Population 
Science.
    Date: October 29, 2015.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 7W030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W266, Rockville, MD 20850, 240-276-6385, 
[email protected].

    Name of Committee: National Cancer Institute, Special Emphasis 
Panel, KRas-Dependent Cancers.
    Date: November 4, 2015.
    Time: 11:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 4W034, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W238, Bethesda, MD 20892-9750 240-276-6371 
[email protected].

    Name of Committee: National Cancer Institute, Special Emphasis 
Panel, Core Infrastructure and Methodological Research for Cancer 
Epidemiology Cohorts.
    Date: November 10, 2015.
    Time: 10:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Cancer Institute Shady Grove, 9609 Medical 
Center Drive, Room 5W030, Rockville, MD 20850, (Telephone Conference 
Call).
    Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review 
Officer, Research Technology and Contract Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W266, Bethesda, MD 20892-9750, 240-276-6385 
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: September 29, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-25068 Filed 10-1-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 191 / Friday, October 2, 2015 / Notices 59791

are identified, and then the mutation- 7W030, Rockville, MD 20850, (Telephone amended (5 U.S.C. App.), notice is
reactive TCRs and engineered Conference Call). hereby given of the following meetings.
peripheral blood T cells from the same Contact Person: Gerald G. Lovinger, Ph.D., The meetings will be closed to the
Scientific Review Officer, Research public in accordance with the
patient are isolated to express these
Technology and Contract Review Branch,
mutation-reactive TCRs. These Division of Extramural Activities, National
provisions set forth in sections
personalized TCR engineered T cells are Cancer Institute, NIH, 9609 Medical Center 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
expanded and infused back into the Drive, Room 7W266, Rockville, MD 20850, as amended. The grant applications and
same patient with the potential to 240–276–6385, lovingeg@mail.nih.gov. the discussions could disclose
induce tumor regression. Name of Committee: National Cancer confidential trade secrets or commercial
The prospective exclusive license Institute, Special Emphasis Panel, KRas- property such as patentable material,
may be granted unless within thirty (30) Dependent Cancers. and personal information concerning
days from the date of this published Date: November 4, 2015. individuals associated with the grant
notice, the NIH receives written Time: 11:00 a.m. to 4:00 p.m. applications, the disclosure of which
evidence and argument that establishes Agenda: To review and evaluate grant would constitute a clearly unwarranted
that the grant of the license would not applications.
Place: National Cancer Institute Shady
invasion of personal privacy.
be consistent with the requirements of Name of Committee: Center for Scientific
Grove, 9609 Medical Center Drive, Room
35 U.S.C. 209 and 37 CFR 404.7. 4W034, Rockville, MD 20850, (Telephone Review Special Emphasis Panel; Gene
Complete applications for a license in Conference Call). Regulatory Networks.
the field of use filed in response to this Contact Person: Jeffrey E. DeClue, Ph.D., Date: October 23, 2015.
notice will be treated as objections to Scientific Review Officer, Research Time: 1:00 p.m. to 6:00 p.m.
the grant of the contemplated exclusive Technology and Contract Review Branch, Agenda: To review and evaluate grant
license. Comments and objections Division of Extramural Activities, National applications.
submitted to this notice will not be Cancer Institute, NIH, 9609 Medical Center Place: National Institutes of Health, 6701
Drive, Room 7W238, Bethesda, MD 20892– Rockledge Drive, Bethesda, MD 20892
made available for public inspection
9750 240–276–6371 decluej@mail.nih.gov. (Virtual Meeting).
and, to the extent permitted by law, will Contact Person: Richard Panniers, Ph.D.,
not be released under the Freedom of Name of Committee: National Cancer
Scientific Review Officer, Center for
Information Act, 5 U.S.C. 552. Institute, Special Emphasis Panel, Core
Scientific Review, National Institutes of
Infrastructure and Methodological Research Health, 6701 Rockledge Drive, Room 2212,
Dated: September 28, 2015. for Cancer Epidemiology Cohorts. MSC 7890, Bethesda, MD 20892, (301) 435–
Richard U. Rodriguez, Date: November 10, 2015. 1741, pannierr@csr.nih.gov.
Acting Director, Office of Technology Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant Name of Committee: Center for Scientific
Transfer, National Institutes of Health. Review Special Emphasis Panel; Member
[FR Doc. 2015–24990 Filed 10–1–15; 8:45 am]
applications.
Conflict: Vascular Biology.
Place: National Cancer Institute Shady
BILLING CODE 4140–01–P Date: October 26–27, 2015.
Grove, 9609 Medical Center Drive, Room
Time: 11:00 a.m. to 4:00 p.m.
5W030, Rockville, MD 20850, (Telephone
Agenda: To review and evaluate grant
Conference Call).
DEPARTMENT OF HEALTH AND applications.
Contact Person: Gerald G. Lovinger, Ph.D.,
HUMAN SERVICES Place: National Institutes of Health, 6701
Scientific Review Officer, Research Rockledge Drive, Bethesda, MD 20892
Technology and Contract Review Branch, (Virtual Meeting).
National Institutes of Health Division of Extramural Activities, National Contact Person: Luis Espinoza, Ph.D.,
Cancer Institute, NIH, 9609 Medical Center Scientific Review Officer, Center for
National Cancer Institute; Notice of Drive, Room 7W266, Bethesda, MD 20892– Scientific Review, National Institutes of
Closed Meetings 9750, 240–276–6385 lovingeg@mail.nih.gov. Health, 6701 Rockledge Drive, Room 4140,
(Catalogue of Federal Domestic Assistance MSC 7814, Bethesda, MD 20892, 301–435–
Pursuant to section 10(d) of the Program Nos. 93.392, Cancer Construction;
Federal Advisory Committee Act, as 0952, espinozala@mail.nih.gov.
93.393, Cancer Cause and Prevention
amended (5 U.S.C. App.), notice is Research; 93.394, Cancer Detection and Name of Committee: Center for Scientific
hereby given of the following meetings. Diagnosis Research; 93.395, Cancer Review Special Emphasis Panel; Member
The meetings will be closed to the Conflict: Topics in Bacterial Pathogenesis
Treatment Research; 93.396, Cancer Biology
and Virulence.
public in accordance with the Research; 93.397, Cancer Centers Support;
Date: October 26, 2015.
provisions set forth in sections 93.398, Cancer Research Manpower; 93.399,
Time: 1:00 p.m. to 5:00 p.m.
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Cancer Control, National Institutes of Health,
Agenda: To review and evaluate grant
as amended. The grant applications and HHS)
applications.
the discussions could disclose Dated: September 29, 2015. Place: National Institutes of Health, 6701
confidential trade secrets or commercial Melanie J. Gray, Rockledge Drive, Bethesda, MD 20892.
property such as patentable material, Program Analyst, Office of Federal Advisory Contact Person: Gagan Pandya, Ph.D.,
and personal information concerning Scientific Review Officer, National Institutes
Committee Policy.
of Health, Center for Scientific Review, 6701
individuals associated with the grant [FR Doc. 2015–25068 Filed 10–1–15; 8:45 am] Rockledge Drive, Rm 3200, MSC 7808,
applications, the disclosure of which BILLING CODE 4140–01–P Bethesda, MD 20892, 301–435–1167,
would constitute a clearly unwarranted pandyaga@mai.nih.gov.
invasion of personal privacy. Name of Committee: Healthcare Delivery
Name of Committee: National Cancer DEPARTMENT OF HEALTH AND and Methodologies Integrated Review Group;
HUMAN SERVICES Biomedical Computing and Health
mstockstill on DSK4VPTVN1PROD with NOTICES

Institute Special Emphasis Panel Bridging the
Gap Between Cancer Mechanism and Informatics Study Section.
Population Science. National Institutes of Health Date: October 29, 2015.
Date: October 29, 2015. Time: 8:00 a.m. to 7:00 p.m.
Time: 1:00 p.m. to 4:00 p.m. Center For Scientific Review; Notice of Agenda: To review and evaluate grant
Agenda: To review and evaluate grant Closed Meetings applications.
applications. Place: Bethesda North Marriott Hotel &
Place: National Cancer Institute Shady Pursuant to section 10(d) of the Conference Center, 5701 Marinelli Road,
Grove, 9609 Medical Center Drive, Room Federal Advisory Committee Act, as Bethesda, MD 20852.

VerDate Sep<11>2014 20:43 Oct 01, 2015 Jkt 238001 PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 E:\FR\FM\02OCN1.SGM 02OCN1

Document Created: 2015-12-15 08:44:52
Document Modified: 2015-12-15 08:44:52

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		October 29, 2015.
FR Citation		80 FR 59791